AACR: How do melanoma cells survive drug treatment long enough to acquire drug resistance?

(University of Colorado Anschutz Medical Campus) 'What we find is that dabrafenib, even at high doses, does not fully turn off the MAPK pathway, thereby enabling eventual escape from drug,' says Sabrina Spencer, Ph.D.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news